Safe Handling of Hazardous Drugs: Practical Considerations for Compounding and Administration

Pharmacists and Pharmacy Techs: New CE Requirements. Click here for more info.

- Multimedia -

Activity Description

Are you at risk for exposure to hazardous drugs? Hazardous medications are capable of causing serious effects in healthcare workers, including local reactions, cancer, organ toxicity, fertility problems, genetic damage, and birth defects. Regulations and guidelines for handling hazardous drugs exist, but exposures still happen. It is important to know how contamination by hazardous drugs can occur and the most effective methods to avoid it.

Learning Objectives

Upon completion of this activity, pharmacists and nurses will be able to:

Define hazardous drugs and negative health effects associated with exposure.
Identify work practices that present a risk of exposure to hazardous drugs.
Outline workplace strategies and practices to reduce exposure and prevent contamination from hazardous drugs.
Describe technological advances that may reduce the exposure of health care providers to hazardous drugs during compounding and administration.

Faculty

Seth Eisenberg, RN, OCN®
Professional Practice Coordinator, Infusion Services
Seattle Cancer Care Alliance
Seattle, WA
Full Bio and Disclosure

Luci A. Power, MS, RPh
Senior Pharmacy Consultant
Power Enterprises
San Francisco, CA
Full Bio and Disclosure

CE Accreditation:

Pharmacists:
ProCE, Inc is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 221-000-09-091-H05-P has been assigned to this knowledge-based home-study activity (initial release date 12-21-09). This activity is acceptable for 1.0 contact hour (0.10 CEU) in states that recognize ACPE providers. It is provided at no cost to participants. Statements of credit will be issued online at www.ProCE.com upon successful completion of the post-test (≥70% correct). No partial credit will be given.

Expiration Date: 12-21-2012

Nurses:
Nurse CE is provided for this activity through collaboration between ProCE, Inc. and Wild Iris Medical Education, Inc. Wild Iris Medical Education, Inc. is accredited as a provider of continuing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity provides 1.0 contact hour of nurse CE credit.

Expiration Date: 12-21-2012

Funding

This activity was supported by an educational grant from ICU Medical, Inc.

To Participate

To participate in this Web-based continuing education activity:
1.	Review the activity description and objectives.
2.	View the activity by clicking on the link below.
3.	Take the online post-test and complete the evaluation by clicking the post-test hyperlink on the final slide of the activity (registration will be required).

View this Activity

	View as Flash
	Download Handouts

Post-Test / Evaluation and CE Statement

To take the post-test, complete the evaluation, and to obtain your CE/CME statement:

New User
Click here to register
Existing User / Not Yet Enrolled in this Course
Click here to enroll
(previous ProCE user that has NOT yet enrolled in this specific course)
Existing User / Already Enrolled in the Course
Click here
(To resume taking the post-test OR Reprint CE Statement)

NOTE: If you attended the webinar titled "Safe Handling of Hazardous Drugs: Practical Considerations for Compounding and Administration" that was held on June 4, August 26, September 24, and November 16, 2009 AND received CE credit (i.e. a pharmacist CE statement of credit or a nurse CE certificate), you are NOT allowed to receive credit again for this home-study web course.

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

Click here for ProCE, Inc.'s Privacy Policy.